Is a complete NBTX research report available?

No complete published report is available for Nanobiotix S.A. (NBTX) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Nanobiotix S.A. (NBTX)

NASDAQ: NBTX · USD

$39.7

+0.15 (+0.4%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-25 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first NBTX analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	2B
Revenue (ttm)	38.3M
Net income (ttm)	-28.1M
EPS (ttm)	-$0.59
Shares out	48.4M
Volume	103,746
Beta	0.56
Price target	$44.4	+11.8%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 38.3M
Net income (ttm): -28.1M
EPS (ttm): -$0.59
Market cap: 2B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	38.3B	72.6x	8.9x	78.4%	+49.7%	-11.8%	Strong Buy
ARGX	argenx SE	55.2B	32.2x	10.4x	50.6%	+58.8%	+48.3%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All NBTX indicators

Market & fundamental data

Available fields

197

Groups with data

Currency

EUR

Showing 197 of 197 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001760854
Company name	Nanobiotix S.A.
Country	France
Country code	US
Cusip	63009J107
Employees	100
Employees Change	-8%
Employees Change Percent	-7.41
Enterprise value	$2.1B
Exchange	NASDAQ
Financial currency	EUR
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2020-12-11
Isin	US63009J1079
Last refreshed	2026-07-25
Market cap	$2B
Market cap category	Mid-Cap
Price	$39.7
Price currency	USD
Rev Per Employee	382,681.7x
Sector	Healthcare
Sector PE	44.87
Sector PE Fwd	23.76
Sic	2834
Symbol	NBTX
Website	https://www.nanobiotix.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-1.39%
EV Sales Forward	58.28x
EV/Sales	54.14x
FCF yield	-1.91%
P/S ratio	52.87x
PS Forward	56.91x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-33.19%
EBITDA Margin	-26.15%
Gross margin	100%
Gross Profit	$38.3M
Gross Profit Growth Q	-81.91%
Gross Profit Growth3 Y	89.68%
Gross Profit Growth5 Y	69.57%
Net Income	$-28.1M
Net Income Growth Years	1%
Pretax Margin	-73.51%
Profit Margin	-73.52%
Profit Per Employee	$-281,331
ROA	-10.06
Roa5y	-28.61
ROCE	-102.2

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	585.39%
Cagr3y	62.85%
Cagr5y	23.5%
EPS Growth Years	1
Revenue Growth Years	1x
Revenue Growth3 Y	89.68x
Revenue Growth5 Y	69.57x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.48
Assets	$79.6M
Cash	$61.9M
Current Assets	$71.4M
Current Liabilities	$65.4M
Debt	$111.9M
Equity	$-99.2M
Interest Coverage	-1.01
Liabilities	$178.8M
Long Term Assets	$8.2M
Long Term Liabilities	$113.3M
Net Cash	$-50M
Net Cash By Market Cap	$-2.47
Tangible Book Value	$-99.2M
Tangible Book Value Per Share	$-2.05
WACC	7.4

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.09
Net Working Capital	$-50.7M
Quick ratio	1.05
Working Capital	$6.2M
Working Capital Turnover	$1.79

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1.17%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	584.48%
200-day SMA	29.48
3Y total return	331.99%
50-day SMA	39.2
50-day SMA vs 200-day SMA	50over200
5Y total return	187.27%
All Time High	57.14
All Time High Change	-30.52%
All Time High Date	2026-05-14
All Time Low	1.75
All Time Low Change	2,168.57%
All Time Low Date	2023-05-01
ATR	2.79
Beta	0.56
Ch YTD	71.71
High	40.4
High52	57.14
High52 Date	2026-05-14
High52ch	-30.52%
Low	39.12
Low52	5.93
Low52 Date	2025-07-24
Low52ch	569.48%
Ma50ch	1.28%
Premarket Change Percent	1.92
Premarket Price	$40.31
Premarket Volume	10,200
Price vs 200-day SMA	34.67%
RSI	53.28
RSI Monthly	81.73
RSI Weekly	59.71
Sharpe ratio	2.28x
Sortino ratio	4.02
Total Return	-1.17%
Tr YTD	71.71
Tr1m	8.47%
Tr1w	5.05%
Tr3m	17.77%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	5
Analyst Count Top	4
Analyst Price Target Top	$34.33
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings Revenue Estimate	165,540,000x
Earnings Revenue Estimate Growth	1,164.15x
Operating Income	$-12.8M
Operating margin	-33.39
Price target	$44.38
Price Target Change	$11.79
Price Target Change Top	$-13.53

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	33,354,039%
Float Percent	68.93%
Net Borrowing	43,448,432.8
Shares Insiders	3.14%
Shares Institutions	14.18%
Shares Out	48,387,950
Shares Qo Q	1.69%
Shares Yo Y	1.17%
Short Ratio	0.69
Short Shares	0.14

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-42.8M
Average Volume	119,476.45x
Bv Per Share	-2.05
CAPEX	$-631,678
Ch1m	8.47
Ch1w	5.05
Ch1y	584.5
Ch3m	17.77
Ch3y	332
Ch5y	187.3
Ch6m	89.59
Change	0.38%
Change From Open	-1.39
Close	39.55
Days Gap	1.8
Depreciation Amortization	447,124.4
Dollar Volume	4,118,716.2
Earnings Date	2026-03-31
Earnings Time	amc
EBIT	$-12.3M
EBITDA	$-9.7M
EPS	$-0.59
F Score	1
FCF	$-38.6M
FCF EV Yield	-1.86x
FCF Per Share	$-0.8
Financing CF	43,930,962
Fiscal Year End	December
Founded	2,003
Income Tax	$3,522
Investing CF	-678,643
Ipr	194.1
Iprfo	118.7
Is Primary Listing	0
Is Spac	No
Last Earnings Date	2026-03-31
Last Report Date	2025-12-31
Last Split Type	Never
Last10k Filing Date	2026-03-31
Ma150	32.03
Ma150ch	23.95%
Ma20	38.81
Ma20ch	2.31%
Net CF	3,538,805
Next Earnings Date	2026-09-17
Open	40.26
Optionable	No
Position In Range	45.31
Ppne	4,744,297.2
Pre Close	39.55
Price Date	2026-07-24
Relative Volume	0.87x
Revenue	38,268,170x
SBC By Revenue	10.86x
Share Based Comp	4,155,219
Tax By Revenue	0.01x
Tr6m	89.59%
Volume	103,746
Z Score	1.11

Nanobiotix S.A. (NBTX)

Coverage state: Market snapshot only — no published research

Generate the first NBTX analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · NBTX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All NBTX indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on NBTX

Frequently asked questions